Cargando…

Identify and Validate the Transcriptomic, Functional Network, and Predictive Validity of FBXL19-AS1 in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common neoplastic diseases worldwide. Available biomarkers are not sensitive enough for the diagnosis of HCC, hence seeking new biomarkers of HCC is urgent and challenging. The purpose of this study was to investigate the role of F-box and leucine-ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Dingdong, Zhang, Xiaokang, Zhu, Xinyu, Maharjan, Narayani, Wang, Yingchao, Luo, Ping, Liang, Chunzi, Tu, Jiancheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744744/ https://www.ncbi.nlm.nih.gov/pubmed/33344260 http://dx.doi.org/10.3389/fonc.2020.609601

Ejemplares similares

Clinical Value and Underlying Mechanisms of Upregulated LINC00485 in Hepatocellular Carcinoma
por: Zhu, Xinyu, et al.
Publicado: (2021)

Diagnostic significance and carcinogenic mechanism of pan‐cancer gene POU5F1 in liver hepatocellular carcinoma
por: He, Dingdong, et al.
Publicado: (2020)

Blood-based Biomarkers for Early Diagnosis of Lung Cancer: A Review Article
por: Maharjan, Narayani, et al.
Publicado: (2020)

circSMAD2 inhibits the epithelial–mesenchymal transition by targeting miR-629 in hepatocellular carcinoma
por: Zhang, Xianwei, et al.
Publicado: (2018)

COVID-19 Diagnosed by Real-Time Reverse Transcriptase-Polymerase Chain Reaction in Nasopharyngeal Specimens of Suspected Cases in a Tertiary Care Center: A Descriptive Cross-sectional Study
por: Maharjan, Narayani, et al.
Publicado: (2021)

Persistent Positivity of Reverse Transcriptase-Polymerase Chain Reaction Test among Patients with COVID-19 in Rural Teaching Hospital : A Descriptive Cross-sectional Study
por: Maharjan, Narayani, et al.
Publicado: (2021)

Comprehensive Analysis Identified ASF1B as an Independent Prognostic Factor for HBV-Infected Hepatocellular Carcinoma
por: Wang, Xianmo, et al.
Publicado: (2022)

Identification and Validation of Tumor Stromal Immunotype in Patients With Hepatocellular Carcinoma
por: Li, Wei, et al.
Publicado: (2019)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)

Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

Homer2 and Homer3 Act as Novel Biomarkers in Diagnosis of hepatitis B virus-induced Hepatocellular Carcinoma
por: Luo, Ping, et al.
Publicado: (2021)

Identification of long non-coding RNA ZFAS1 as a novel biomarker for diagnosis of HCC
por: Luo, Ping, et al.
Publicado: (2018)

Development and Validation of Epigenetic Modification-Related Signals for the Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Lu, Maoqing, et al.
Publicado: (2021)

Construction and validation of a prognostic model of pyroptosis related genes in hepatocellular carcinoma
por: Li, Guanqun, et al.
Publicado: (2022)

Development and Validation of a Prognostic Nomogram for Hypopharyngeal Carcinoma
por: Tian, Shu, et al.
Publicado: (2021)

Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma
por: Ni, Wenkai, et al.
Publicado: (2021)

Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma
por: Li, Shuai, et al.
Publicado: (2021)

Identification and Validation of Hub Genes Associated With Hepatocellular Carcinoma Via Integrated Bioinformatics Analysis
por: Wang, Sumei, et al.
Publicado: (2021)

Development and Validation of a nomogram for forecasting survival of alcohol related hepatocellular carcinoma patients
por: Yan, Tao, et al.
Publicado: (2022)

Association between 8q24 rs6983267 polymorphism and cancer susceptibility: a meta-analysis involving 170,737 subjects
por: Zhu, Man, et al.
Publicado: (2017)

Identifying Apoptosis-Related Transcriptomic Aberrations and Revealing Clinical Relevance as Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Zhu, Jinyu, et al.
Publicado: (2021)

Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma
por: Tian, Siyuan, et al.
Publicado: (2021)

The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Metabolism-Associated Gene Signatures for FDG Avidity on PET/CT and Prognostic Validation in Hepatocellular Carcinoma
por: Lee, Hyunjong, et al.
Publicado: (2022)

The Circular RNA hsa_circ_0001445 Regulates the Proliferation and Migration of Hepatocellular Carcinoma and May Serve as a Diagnostic Biomarker
por: Zhang, Xianwei, et al.
Publicado: (2018)

Identification and validation of four photodynamic therapy related genes inhibiting MAPK and inducing cell cycle alteration in squamous cell carcinoma
por: Zhao, Yingchao, et al.
Publicado: (2022)

Construction and validation of a prognostic model with RNA binding protein-related mRNAs for the HBV-related hepatocellular carcinoma patients
por: Xu, Shaohua, et al.
Publicado: (2022)

Development and Validation of a Machine Learning Prognostic Model for Hepatocellular Carcinoma Recurrence After Surgical Resection
por: Huang, Yao, et al.
Publicado: (2021)

Identification and Validation of an 6-Metabolism-Related Gene Signature and Its Correlation With Immune Checkpoint in Hepatocellular Carcinoma
por: Ren, He, et al.
Publicado: (2021)

Development and Validation of a Novel Model to Predict Regional Lymph Node Metastasis in Patients With Hepatocellular Carcinoma
por: Chen, Xiaoyuan, et al.
Publicado: (2022)

Notch and the pre-TCR coordinate thymocyte proliferation by induction of the SCF subunits Fbxl1 and Fbxl12
por: Zhao, Bin, et al.
Publicado: (2019)

Prognostic Role of Tenascin-C for Cancer Outcome: A Meta-Analysis
por: Ming, Xinliang, et al.
Publicado: (2019)

A Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatocellular Carcinoma: Single-Center Analyses With Internal Validation
por: Yang, Jiarui, et al.
Publicado: (2021)

Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Construction and validation of a prediction model of extrahepatic metastasis for hepatocellular carcinoma based on common clinically available data
por: Zhou, Liuxin, et al.
Publicado: (2022)

FBXL19 promotes malignant behaviours by activating MAPK signalling and negatively correlates with prognosis in hepatocellular carcinoma
por: Xun, Min, et al.
Publicado: (2023)

Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma
por: Wang, Tao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kbl4qidgg3g4i4mak8u1n82ion